Four Tickers That Turn $1 Million Into $60,000 of Annual Income

A million dollars sounds like enough to retire on. Whether it actually is depends entirely on what you make it do. At a blended yield of roughly 6%, $1,000,000 produces exactly $60,000 per year in investment income. Four tickers currently sitting in that yield range are Pfizer (NYSE:PFE | PFE Price Prediction), Altria Group (NYSE:MO), Verizon Communications (NYSE:VZ), and Enterprise Products Partners (NYSE:EPD). Each carries distinct risks and illustrates what it costs to buy $60,000 a year at different points on the yield spectrum.

Capital Required Across Three Yield Tiers

The math is simple: income target divided by yield equals capital required. At 3.5%, you need approximately $1,714,000 to generate $60,000 annually. At 6%, you need exactly $1,000,000. At 10%, you need $600,000.

Conservative tier (3% to 4% yield). Broad dividend growth funds and blue-chip equities live here. You need the most capital, but the portfolio is diversified, dividends typically grow over time, and principal is most likely to appreciate. The 10-year Treasury now yields close to 5%, which means a conservative dividend growth portfolio offers only a thin income premium over risk-free government bonds. The case for this tier is long-term compounding, not current income.

Moderate tier (5% to 7% yield). This is where PFE, MO, VZ, and EPD cluster. At 6%, the equation yields exactly $1,000,000 in required capital. The four tickers each carry yields in the 6% range: Pfizer at approximately 6.2%, Altria at approximately 6.4%, Verizon at approximately 5.7%, and Enterprise Products Partners at approximately 6%. A portfolio weighted toward the higher-yielding names closes the gap to a blended 6%. The capital requirement drops roughly $700,000 compared to the conservative tier, a meaningful difference for those below the $1.7 million threshold.

Aggressive tier (8% to 14% yield). Leveraged covered call funds, mortgage REITs, and business development companies populate this range. At 10%, you need $600,000. The capital requirement is lowest, but principal erosion is common, distributions can be cut without warning, and the portfolio may shrink in value even while generating income. This tier works best as a supplement to a larger portfolio, not a standalone income engine.

Four Tickers, Four Risk Profiles: Pharma, Tobacco, Telecom, and Pipelines

Pfizer’s yield is elevated partly because the stock has spent years under pressure from a post-COVID revenue hangover. The company posted a GAAP net loss in Q4 2025 due to non-cash impairment charges, but full-year 2025 net income came in at $7.8 billion and the dividend is covered on an adjusted basis. The company has guided for 2026 adjusted EPS of $2.80 to $3.00 and revenue of $59.5 to $62.5 billion. The quarterly dividend has held at $0.43 per share and represents the 349th consecutive quarterly payment in the company’s history. One caution worth flagging: Pfizer’s annual raise streak, which ran for more than a decade, stalled in 2026 as the January payment matched the prior year rather than stepping up. Management has pledged to maintain the payout and resume growth once the loss-of-exclusivity period clears. That patent cliff carries an estimated $1.5 billion in revenue headwind for 2026.

Altria’s domestic cigarette volume has been declining structurally for years, yet the company has continued raising its payout. In August 2026, the board approved a 4.7% increase to $1.11 per share quarterly, marking the 61st dividend increase in 57 years. The annualized rate now stands at $4.44 per share. The company returned $8 billion to shareholders in 2025 and has guided for 2026 adjusted EPS of $5.56 to $5.72. Volume decline remains the structural headwind; pricing power and growth in oral nicotine products are the primary offsets.

Verizon carries substantial debt. The Frontier Communications acquisition, completed in 2025, pushed total debt to approximately $172.5 billion, lifting leverage to 2.5 times EBITDA above management’s long-term target range. What keeps the dividend credible is free cash flow. The company generated $20.1 billion in free cash flow in 2025 and has guided for at least $21.5 billion in 2026. The most recent quarterly payment is $0.7075 per share, an annualized $2.83, and the company has now delivered 20 consecutive years of dividend increases.

Enterprise Products Partners is a midstream energy master limited partnership that moves natural gas, crude oil, and petrochemicals through pipelines and charges fees regardless of commodity prices. That fee-based model insulates distributions from the price swings that affect upstream producers. EPD has grown its distribution for 28 consecutive years, with the most recent quarterly distribution at $0.55 per unit, covered approximately 1.8 times by distributable cash flow. Note: MLP ownership generates a K-1 tax form, adding complexity at filing time.

The Growth Advantage Hidden in Lower Yields

A 3.5% yield that grows 8% annually doubles the income stream in roughly nine years. A 10% yield with no growth stays flat or declines if principal erodes. At $60,000 per year, that difference is the gap between an income stream that keeps pace with inflation and one that quietly loses purchasing power.

Altria’s dividend history makes the compounding argument concrete. The quarterly payment was $0.44 in Q1 1999. Today it stands at $1.11. An investor who bought at that earlier, lower yield is now collecting a dramatically higher effective return on original cost. That is the case for dividend growth: the passage of time turns a modest yield into a powerful one.

The moderate tier represents a reasonable middle ground. It delivers enough current income to approximate a salary replacement without the principal erosion risk common in the aggressive tier, and without demanding the $1.7 million capital base of the conservative tier. The key tradeoff is sector concentration: four tickers across pharma, tobacco, telecom, and pipelines is not a diversified portfolio by itself.

Three Steps Before Building This Portfolio

1. Calculate your actual annual spending. Many people need to replace less than $60,000 after taxes, mortgage payoff, and reduced work-related expenses. A lower income target drops the capital requirement at every yield tier.
2. Model the tax treatment separately. Qualified dividends from Pfizer and Altria are taxed differently than Verizon’s ordinary dividends and Enterprise Products Partners’ K-1 distributions, which may include return of capital. The after-tax income number is what actually hits your account.
3. Compare total return across tiers, not yield alone. With the 10-year Treasury now near 5%, the income gap between a conservative dividend growth fund and a risk-free government bond has narrowed considerably. Whether the added complexity and sector concentration of the moderate tier is worth it depends on your time horizon and how much you need the capital to grow alongside the income.

Editor’s note: This update raises Altria’s quarterly dividend to $1.11 per share (a 4.7% increase announced in August 2026, the company’s 61st raise in 57 years), updates Verizon’s quarterly dividend to $0.7075 and its consecutive-increase streak to 20 years, revises Verizon’s 2025 free cash flow to $20.1 billion and notes the Frontier acquisition lifted total debt to approximately $172.5 billion, extends Enterprise Products Partners’ distribution growth streak to 28 consecutive years, and updates the 10-year Treasury yield reference from approximately 4.3% to approximately 5%, reflecting the current rate environment.

Contact [email protected] for any questions or corrections.